Trial intelligence / Profile preview

ASPRE: Aspirin for Pre-eclampsia Prevention

NCT02301780Phase 3Completed

Sponsor
Rabin Medical Center
Start
Dec 2015
Primary completion
Oct 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of aspirin in preeclampsia, sponsored by Rabin Medical Center. Started Dec 2015; status: completed.

02

Drugs

aspirin
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT02301780.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02301780.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call